TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
59.83
+1.85 (3.18%)
At close: Nov 6, 2026, 4:00 PM EST
59.75
-0.08 (-0.13%)
After-hours: Nov 6, 2026, 7:45 PM EST
TG Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Cash & Equivalents | 482.58 | 442.21 | 79.15 | 74.08 | 129.13 | 132.14 | 179.89 | 195.82 | 82.91 | 75.48 | 92.93 | 150.9 | 97.01 | 61.47 | 102.3 | 109.86 | 147.07 | 185.68 | 298.89 | 326.51 |
Short-Term Investments | 69.67 | 72.22 | 62.82 | 57.5 | 122.74 | 144.1 | 131.11 | 145.22 | 134.34 | 134.31 | 124.58 | 78.26 | 47.9 | 78.24 | 59.37 | 66.08 | 48.64 | 47.53 | 15.88 | 30.34 |
Cash & Short-Term Investments | 552.25 | 514.43 | 141.97 | 131.58 | 251.87 | 276.24 | 311 | 341.04 | 217.25 | 209.79 | 217.51 | 229.16 | 144.91 | 139.71 | 161.68 | 175.94 | 195.71 | 233.2 | 314.76 | 356.85 |
Cash Growth (YoY) | 119.26% | 86.23% | -54.35% | -61.42% | 15.93% | 31.68% | 42.98% | 48.82% | 49.93% | 50.16% | 34.53% | 30.25% | -25.96% | -40.09% | -48.63% | -50.70% | -55.87% | -55.48% | -48.01% | 40.41% |
Accounts Receivable | 401.57 | 392.05 | 305.63 | 265.38 | 231.52 | 190.12 | 129.19 | 115.73 | 83.61 | 64.98 | 51.09 | 39.32 | 17.48 | 8.62 | - | - | 0.09 | 0.9 | 1.39 | 1.38 |
Receivables | 401.57 | 392.05 | 305.63 | 265.38 | 231.52 | 190.12 | 129.19 | 115.73 | 83.61 | 64.98 | 51.09 | 39.32 | 17.48 | 8.62 | - | - | 0.09 | 0.9 | 1.39 | 1.38 |
Inventory | 147.97 | 129.03 | 125.59 | 146.95 | 155.2 | 157.76 | 110.46 | 84.67 | 81.24 | 77.72 | 39.82 | 33.55 | 30.23 | 27.22 | - | - | - | - | - | - |
Other Current Assets | 43.9 | 51.46 | 57.58 | 55.85 | 25.37 | 20.39 | 15.72 | 32.63 | 7.05 | 8.1 | 9.52 | 17.08 | 15.95 | 9.23 | 6.6 | 6.98 | 6.76 | 8.11 | 14.81 | 13.55 |
Total Current Assets | 1,146 | 1,087 | 630.76 | 599.77 | 663.96 | 644.51 | 566.36 | 574.07 | 389.15 | 360.58 | 317.94 | 319.11 | 208.57 | 184.78 | 168.27 | 182.92 | 202.56 | 242.22 | 330.97 | 371.78 |
Property, Plant & Equipment | 7.09 | 6.48 | 6.28 | 6.5 | 6.72 | 6.93 | 7.15 | 7.41 | 7.66 | 7.97 | 8.05 | 8.4 | 8.68 | 8.93 | 9.2 | 9.46 | 9.23 | 9.49 | 9.23 | 9.4 |
Long-Term Investments | 64.37 | 61.54 | 59.14 | 48.76 | 28.59 | 1.91 | 0.81 | 1.13 | 0.95 | 1.32 | - | - | - | - | 12.4 | 21.77 | 36.08 | 47.47 | 35.53 | 24.55 |
Goodwill | - | - | - | - | - | - | - | - | - | 0.8 | - | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 |
Long-Term Deferred Tax Assets | 343.43 | 344.14 | 348 | 366.63 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Long-Term Deferred Charges | - | - | - | - | - | - | - | - | - | 1.36 | - | 1.47 | 1.52 | 1.57 | 1.63 | 1.68 | 1.73 | 1.79 | 1.84 | 1.89 |
Other Long-Term Assets | 79.06 | 29.71 | 19.08 | 3.37 | 3.34 | 3.35 | 3.37 | 3.41 | 3.45 | 1.29 | 3.59 | 1.28 | 1.28 | 1.28 | 1.27 | 1.27 | 1.27 | 1.27 | 1.26 | 1.26 |
Total Assets | 1,640 | 1,529 | 1,063 | 1,025 | 702.61 | 656.69 | 577.69 | 586.01 | 401.21 | 373.32 | 329.59 | 331.07 | 220.85 | 197.36 | 193.57 | 217.89 | 251.67 | 303.03 | 379.63 | 409.69 |
Liabilities
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Accounts Payable | 120.09 | 69.25 | 47.41 | 61.64 | 86.52 | 93.83 | 37.4 | 77.01 | 71.87 | 72.27 | 29.27 | 33.64 | 59.15 | 55.19 | 42.02 | 29.43 | 36.32 | 48.37 | 50.89 | 44.3 |
Accrued Expenses | 59.51 | 39.26 | 41.05 | 15.01 | 10.61 | 5.14 | 15.19 | 10.09 | 6.35 | 3.6 | 12.17 | 8.34 | 6.64 | 3.22 | 8.43 | 4.3 | 2.88 | 1.62 | 10.17 | 12.86 |
Current Portion of Long-Term Debt | - | - | 0.69 | 0.82 | 0.81 | 0.87 | 0.66 | - | 0.38 | 0.32 | 0.36 | 0.17 | - | 0.3 | 0.24 | 0.12 | 0.08 | 0.18 | 1.34 | 16.62 |
Current Portion of Leases | 1.91 | 1.82 | 1.04 | 1.07 | 1.09 | 1.12 | 1.16 | 1.23 | 1.31 | 1.38 | 1.45 | 1.48 | 1.51 | 1.55 | 1.58 | 1.62 | 1.48 | 1.49 | 1.44 | 1.47 |
Current Unearned Revenue | 16.83 | 17.19 | 21.23 | 26.4 | 23.91 | 17.08 | 11.41 | 9.09 | 3.37 | 3.37 | 0.15 | 7.1 | - | 0.2 | - | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
Other Current Liabilities | 70.16 | 59.6 | 42.34 | 51.87 | 48.95 | 42.17 | 24.87 | 27.7 | 25.38 | 18.74 | 10.32 | 6.95 | 5.37 | 2.62 | 0.93 | 0.79 | 2.36 | 2.79 | 1.35 | 12.21 |
Total Current Liabilities | 268.49 | 187.11 | 153.76 | 156.81 | 171.89 | 160.21 | 90.68 | 125.11 | 108.66 | 99.68 | 53.72 | 57.68 | 72.67 | 63.08 | 53.2 | 36.45 | 43.33 | 54.66 | 65.38 | 87.66 |
Long-Term Debt | 745.39 | 745.14 | 245.65 | 245.34 | 245.04 | 244.73 | 244.43 | 244.16 | 102.54 | 101.33 | 100.12 | 98.91 | 97.7 | 96.5 | 71.14 | 70.04 | 68.95 | 67.25 | 66.79 | - |
Long-Term Leases | 7.14 | 6.6 | 7.02 | 7.31 | 7.59 | 7.86 | 8.13 | 8.42 | 8.7 | 8.96 | 9.23 | 9.52 | 9.81 | 10.08 | 10.34 | 10.58 | 9.98 | 10.32 | 9.85 | 10.02 |
Long-Term Unearned Revenue | 14.53 | 6.86 | 8.81 | 8.35 | 1.67 | 6.6 | 12.09 | 16.17 | 3.74 | 3.24 | 6.02 | 0.19 | 0.23 | 0.27 | 0.31 | 0.34 | 0.38 | 0.42 | 0.46 | 0.5 |
Total Liabilities | 1,036 | 945.71 | 415.23 | 417.81 | 426.18 | 419.4 | 355.33 | 393.86 | 223.64 | 213.21 | 169.09 | 166.3 | 180.4 | 169.93 | 134.99 | 117.41 | 122.63 | 132.64 | 142.48 | 98.17 |
Shareholders' Equity
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Common Stock | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.14 | 0.14 |
Additional Paid-In Capital | 1,859 | 1,845 | 1,830 | 1,812 | 1,794 | 1,776 | 1,760 | 1,747 | 1,734 | 1,685 | 1,713 | 1,665 | 1,654 | 1,594 | 1,586 | 1,575 | 1,567 | 1,568 | 1,566 | 1,547 |
Retained Earnings | -1,054 | -1,062 | -1,082 | -1,105 | -1,496 | -1,524 | -1,529 | -1,553 | -1,556 | -1,525 | -1,553 | -1,500 | -1,614 | -1,566 | -1,527 | -1,474 | -1,438 | -1,398 | -1,329 | -1,235 |
Treasury Stock | -200.23 | -200.23 | -100.23 | -100.23 | -21.99 | -15.12 | -8.99 | -2.38 | -0.23 | -0.23 | -0.23 | -0.23 | -0.23 | -0.23 | -0.23 | -0.23 | -0.23 | -0.23 | -0.23 | -0.23 |
Shareholders' Equity | 604.08 | 583.13 | 648.02 | 607.22 | 276.43 | 237.29 | 222.36 | 192.16 | 177.57 | 160.11 | 160.5 | 164.77 | 40.45 | 27.43 | 58.59 | 100.48 | 129.04 | 170.39 | 237.15 | 311.52 |
Total Liabilities & Equity | 1,640 | 1,529 | 1,063 | 1,025 | 702.61 | 656.69 | 577.69 | 586.01 | 401.21 | 373.32 | 329.59 | 331.07 | 220.85 | 197.36 | 193.57 | 217.89 | 251.67 | 303.03 | 379.63 | 409.69 |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Total Debt | 754.44 | 753.56 | 254.4 | 254.54 | 254.53 | 254.58 | 254.38 | 253.81 | 112.92 | 111.99 | 111.15 | 110.08 | 109.02 | 108.43 | 83.3 | 82.36 | 80.49 | 79.24 | 79.41 | 28.11 |
Net Cash (Debt) | -202.19 | -239.13 | -112.43 | -122.96 | -2.66 | 21.66 | 56.62 | 87.23 | 104.33 | 97.79 | 106.36 | 119.08 | 35.89 | 31.28 | 78.38 | 93.59 | 115.22 | 153.96 | 235.36 | 328.74 |
Net Cash Growth (YoY) | - | - | - | - | - | -77.85% | -46.76% | -26.74% | 190.72% | 212.65% | 35.70% | 27.24% | -68.85% | -79.68% | -66.70% | -71.53% | -71.75% | -67.99% | -58.16% | 54.63% |
Net Cash Per Share | -1.29 | -1.49 | -0.71 | -0.76 | -0.02 | 0.13 | 0.35 | 0.54 | 0.65 | 0.67 | 0.74 | 0.76 | 0.25 | 0.22 | 0.57 | 0.69 | 0.85 | 1.15 | 1.78 | 2.48 |
Filing Date Shares Outstanding | 141.85 | 141.72 | 147.68 | 146.2 | 145.9 | 145.82 | 145.23 | 143.52 | 143.45 | 143.14 | 144.78 | 141.46 | 141.15 | 138.9 | 137.63 | 133.92 | 135.27 | 132.98 | 130.79 | 130.95 |
Total Common Shares Outstanding | 141.86 | 141.73 | 143.29 | 142.68 | 145.26 | 145.23 | 143.99 | 143.63 | 143.46 | 143.17 | 141.79 | 141.49 | 141.1 | 138.9 | 137.65 | 133.93 | 135.15 | 133.09 | 131.22 | 130.95 |
Working Capital | 877.19 | 899.86 | 477 | 442.96 | 492.07 | 484.3 | 475.68 | 448.96 | 280.49 | 260.9 | 264.22 | 261.44 | 135.91 | 121.71 | 115.07 | 146.48 | 159.23 | 187.56 | 265.58 | 284.12 |
Book Value Per Share | 4.26 | 4.11 | 4.52 | 4.26 | 1.90 | 1.63 | 1.54 | 1.34 | 1.24 | 1.12 | 1.13 | 1.16 | 0.29 | 0.20 | 0.43 | 0.75 | 0.95 | 1.28 | 1.81 | 2.38 |
Tangible Book Value | 604.08 | 583.13 | 648.02 | 607.22 | 276.43 | 237.29 | 222.36 | 192.16 | 177.57 | 159.31 | 160.5 | 163.97 | 39.65 | 26.63 | 57.79 | 99.68 | 128.24 | 169.59 | 236.35 | 310.72 |
Tangible Book Value Per Share | 4.26 | 4.11 | 4.52 | 4.26 | 1.90 | 1.63 | 1.54 | 1.34 | 1.24 | 1.11 | 1.13 | 1.16 | 0.28 | 0.19 | 0.42 | 0.74 | 0.95 | 1.27 | 1.80 | 2.37 |